|
|
Volumn 3, Issue 1, 2004, Pages 76-87
|
|
I Latin American Congress of Autoimmunity Galapagos - September 15-18
a
b,c
b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ANTIBIOTIC AGENT;
ANTICOAGULANT AGENT;
ANTIRHEUMATIC AGENT;
ANTITHROMBIN III;
AZATHIOPRINE;
COLESTYRAMINE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ESTROGEN DERIVATIVE;
ETANERCEPT;
FIBRINOLYTIC AGENT;
GLUCOCORTICOID;
HEPARIN;
HYDROCORTISONE;
HYDROXYCHLOROQUINE;
IMMUNOGLOBULIN;
INFLIXIMAB;
LEFLUNOMIDE;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROTEIN C;
PROTEIN S;
RECOMBINANT PROTEIN;
SALAZOSULFAPYRIDINE;
STEROID;
THALIDOMIDE;
TUMOR NECROSIS FACTOR ANTAGONIST;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ADULT RESPIRATORY DISTRESS SYNDROME;
ANTIPHOSPHOLIPID SYNDROME;
AORTA ARCH SYNDROME;
AUTOIMMUNE DISEASE;
AUTOIMMUNITY;
BULLOUS SKIN DISEASE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOKINE RELEASE;
DIAGNOSTIC ACCURACY;
DRUG CONTRAINDICATION;
DRUG INDICATION;
EPIDEMIOLOGICAL DATA;
FETUS DISEASE;
FETUS WASTAGE;
HUMAN;
LUNG DISEASE;
LUPUS ERYTHEMATOSUS;
MEDICAL PRACTICE;
MOLECULAR MIMICRY;
NONHUMAN;
ORGANIZATION;
PLASMAPHERESIS;
PREGNANCY COMPLICATION;
PSORIASIS;
RHEUMATOID ARTHRITIS;
SIDE EFFECT;
SJOEGREN SYNDROME;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THROMBOPHILIA;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
|
EID: 1042278940
PISSN: 15689972
EISSN: None
Source Type: Journal
DOI: 10.1016/j.autrev.2003.10.004 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
